Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

ORMP — Oramed Pharmaceuticals Inc.

EXPENSIVE (MOS -3.0%) · Quality 96/100

ORMP - Oramed Pharmaceuticals Inc.
Data generated 2026-09-19 21:53 UTC (nightly scan, universe: Russell 3000).
Price: 4.74 USD
Intrinsic value: 4.6 USD
Margin of safety: -3.0%
Implied growth (reverse DCF): +20.4% (model assumes +20.0%)
Valuation: EXPENSIVE
Value Score: 40.8
Quality: 96/100
Moat score: 26.7 (erosion: none)
EXPENSIVE (MOS -3.0%) - Quality 96/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ORMP
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

4.74

Intrinsic value

4.6

Margin of safety

-3.0%

Implied growth (reverse DCF)

+20.4%

model assumes +20.0%

Value Score

40.8

Quality

Psychology

-1.2

Discovery

27.7

price/volume attention only

Moat score

26.7

erosion: none

Value Score: top 34% of Russell 3000 · Quality: top 1%

Dividend: 0.25/share (TTM) · yield 5.3% · payout 6%

Open the interactive Deep Dive for ORMP →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ORMP - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ORMP undervalued?

As of 2026-09-19, ORMP trades at 4.74 against a computed intrinsic value of 4.6 (-3.0% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Oramed Pharmaceuticals Inc.'s Value Score?

Oramed Pharmaceuticals Inc.'s Value Score is 40.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.

Does ORMP pay a dividend?

Yes - ORMP's trailing twelve-month dividend is 0.25/share, a yield of 5.3% at the current price (as of 2026-09-19).